Prime Day Logo

3 months free

Prime Members Exclusive
audible, an amazon company
  • English - USD
    • Language
      English
      Currency
      USD - US Dollar
  • Sign in
  • Browse

    Get Started

    • Audiobooks
    • Podcasts
    • Audible Originals
    • Sleep
    • Latino and Hispanic voices
    • All categories
    • Plans & Pricing

    Popular Lists

    • Bestsellers
    • Coming Soon
    • New Releases
    • Best of the Best
    • Series
    • Authors
    • Editors’ Picks
    • Best of the year

    Explore Audible

    • Plus Catalog
    • Gifts
    • Help Center
    • About Audible
    • Blog
    • Sales & deals
Health & Wellness Physical Illness & Disease Perspectives on Selected Myasthenia Gravis Posters and Abstracts From AANEM

Episodes

  • Wrap Up

    Wrap Up

    Nov 19 2024
    2 mins

    Failed to add items

    Sorry, we are unable to add the item because your shopping cart is already at capacity.

    Add to Cart failed.

    Please try again later

    Add to Wish List failed.

    Please try again later

    Remove from wishlist failed.

    Please try again later

    Adding to library failed

    Please try again

    Follow podcast failed

    Please try again

    Unfollow podcast failed

    Please try again
    Listen for free
  • Long-Term Safety and Efficacy of Zilucoplan in Generalized Myasthenia Gravis 120-Week Interim Analysis of RAISE-XT

    Long-Term Safety and Efficacy of Zilucoplan in Generalized Myasthenia Gravis 120-Week Interim Analysis of RAISE-XT

    Nov 19 2024

    Author: Howard, JF, et al.
    Overview Provided by Nicolas Silvestri, MD

    Show more Show less
    3 mins

    Failed to add items

    Sorry, we are unable to add the item because your shopping cart is already at capacity.

    Add to Cart failed.

    Please try again later

    Add to Wish List failed.

    Please try again later

    Remove from wishlist failed.

    Please try again later

    Adding to library failed

    Please try again

    Follow podcast failed

    Please try again

    Unfollow podcast failed

    Please try again
    Listen for free
  • Efficacy and Safety of Nipocalimab in Patients with Generalized Myasthenia Gravis: Topline Results from the Double-Blind, Placebo-Controlled, Randomized Phase 3 VIVACITY-MG3 Study

    Efficacy and Safety of Nipocalimab in Patients with Generalized Myasthenia Gravis: Topline Results from the Double-Blind, Placebo-Controlled, Randomized Phase 3 VIVACITY-MG3 Study

    Nov 19 2024

    Author: Strober J, et al.
    Overview Provided by Nicolas Silvestri, MD

    Show more Show less
    3 mins

    Failed to add items

    Sorry, we are unable to add the item because your shopping cart is already at capacity.

    Add to Cart failed.

    Please try again later

    Add to Wish List failed.

    Please try again later

    Remove from wishlist failed.

    Please try again later

    Adding to library failed

    Please try again

    Follow podcast failed

    Please try again

    Unfollow podcast failed

    Please try again
    Listen for free
  • Concomitant Corticosteroid Use with Ravulizumab in Adults with Anti-Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: Phase 3 CHAMPION-MG Open-Label Extension Final Results

    Concomitant Corticosteroid Use with Ravulizumab in Adults with Anti-Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: Phase 3 CHAMPION-MG Open-Label Extension Final Results

    Nov 19 2024

    Author: Nicolle M, et al.
    Overview Provided by Nicolas Silvestri, MD

    Show more Show less
    3 mins

    Failed to add items

    Sorry, we are unable to add the item because your shopping cart is already at capacity.

    Add to Cart failed.

    Please try again later

    Add to Wish List failed.

    Please try again later

    Remove from wishlist failed.

    Please try again later

    Adding to library failed

    Please try again

    Follow podcast failed

    Please try again

    Unfollow podcast failed

    Please try again
    Listen for free
  • Cyclic and Every-Other-Week Dosing of Intravenous Efgartigimod for Generalized Myasthenia Gravis Part A of ADAPT NXT

    Cyclic and Every-Other-Week Dosing of Intravenous Efgartigimod for Generalized Myasthenia Gravis Part A of ADAPT NXT

    Nov 19 2024

    Author: Habib AA, et al
    Overview Provided by Nicolas Silvestri, MD

    Show more Show less
    3 mins

    Failed to add items

    Sorry, we are unable to add the item because your shopping cart is already at capacity.

    Add to Cart failed.

    Please try again later

    Add to Wish List failed.

    Please try again later

    Remove from wishlist failed.

    Please try again later

    Adding to library failed

    Please try again

    Follow podcast failed

    Please try again

    Unfollow podcast failed

    Please try again
    Listen for free
  • Introduction

    Introduction

    Nov 19 2024
    2 mins

    Failed to add items

    Sorry, we are unable to add the item because your shopping cart is already at capacity.

    Add to Cart failed.

    Please try again later

    Add to Wish List failed.

    Please try again later

    Remove from wishlist failed.

    Please try again later

    Adding to library failed

    Please try again

    Follow podcast failed

    Please try again

    Unfollow podcast failed

    Please try again
    Listen for free
© Copyright 1997 - 2025 Audible Inc. About Audible Careers Conditions of Use Privacy Notice Interest-Based Ads License Cookies Your ads privacy choices United States (English)